Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

PERTUZUMAB for Breast neoplasm: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 107 adverse event reports in the FDA FAERS database where PERTUZUMAB was used for Breast neoplasm.

Most Reported Side Effects for PERTUZUMAB

Side Effect Reports % Deaths Hosp.
Diarrhoea 3,343 15.2% 312 1,647
Off label use 1,886 8.6% 373 655
Fatigue 1,672 7.6% 249 799
Nausea 1,669 7.6% 203 858
Myelosuppression 1,311 6.0% 3 637
Disease progression 1,142 5.2% 401 306
Vomiting 1,096 5.0% 128 691
Dyspnoea 987 4.5% 86 565
Neuropathy peripheral 983 4.5% 161 347
Pyrexia 926 4.2% 86 596
Neutropenia 856 3.9% 165 368
Death 807 3.7% 807 78
Rash 807 3.7% 18 198
Alopecia 801 3.6% 116 255
Anaemia 756 3.4% 52 356

Other Indications for PERTUZUMAB

Breast cancer (7,532) Breast cancer metastatic (3,784) Her2 positive breast cancer (3,037) Product used for unknown indication (2,659) Her-2 positive breast cancer (2,005) Invasive ductal breast carcinoma (633) Breast cancer female (419) Invasive breast carcinoma (322) Neoplasm malignant (217) Breast cancer stage iv (128)

Other Drugs Used for Breast neoplasm

PACLITAXEL (299) TRASTUZUMAB (233) PALBOCICLIB (171) CYCLOPHOSPHAMIDE (120) DOCETAXEL (117) LETROZOLE (111) CARBOPLATIN (105) RIBOCICLIB (90) CAPECITABINE (76) EPIRUBICIN (70)

Related Pages

PERTUZUMAB Full Profile All Breast neoplasm Drugs PERTUZUMAB Demographics PERTUZUMAB Timeline